| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jan 28, 2019 | BCRX Biocryst Pharmaceuticals Inc | Staab Thomas R II | Senior Vice President And CFO | Sell | 5,000 | $9.85 | $49,250.00 | -3.7% | |
| Jan 28, 2019 | TLRY Tilray Brands, Inc. | Pastorius Edward Wood Jr | Chief Revenue Officer | Sell | 29,422 | $72.57 | $2,135,154.54 | -66.7% | |
| Jan 28, 2019 | BCRX Biocryst Pharmaceuticals Inc | Powell Lynne | Senior VP - CCO | Sell | 12,000 | $9.75 | $116,940.00 | -100% | |
| Jan 25, 2019 | IRWD Ironwood Pharmaceuticals Inc | Hecht Peter M | Chief Executive Officer | Sell | 89,551 | $12.53 | $1,122,208.73 | -0.6% | |
| Jan 25, 2019 | BUDZ Weed, Inc. | Breen Nicole M | Secretary And Treasurer | Sell | 15,950 | $1.50 | $23,865.00 | - | |
| Jan 24, 2019 | TLRY Tilray Brands, Inc. | Kennedy Brendan87 | President And CEO | Sell | 149,916 | $74.21 | $11,125,146.43 | -38.5% | |
| Jan 24, 2019 | TLRY Tilray Brands, Inc. | Pastorius Edward Wood Jr | Chief Revenue Officer | Sell | 20,578 | $74.21 | $1,527,076.92 | -31.8% | |
| Jan 24, 2019 | PAHC Phibro Animal Health Corp | Bendheim Daniel M | Exec. VP, Corporate Strategy | Sell | 7,500 | $31.63 | $237,254.00 | -92.7% | |
| Jan 24, 2019 | AMRN Amarin Corp Plc\uk | Kennedy Joseph T | General Counsel | Sell | 1,040,194 | $17.77 | $18,487,911.33 | -70.5% | |
| Jan 23, 2019 | AMPH Amphastar Pharmaceuticals, Inc. | Shandell Jason B. | President And General Counsel | Sell | 15,497 | $22.39 | $347,019.46 | -4.4% | |
| Jan 23, 2019 | AMPH Amphastar Pharmaceuticals, Inc. | Liawatidewi Yakob47 | SVP Corp Admin Center | Sell | 7,000 | $22.52 | $157,650.00 | -8.5% | |
| Jan 18, 2019 | BCRX Biocryst Pharmaceuticals Inc | Powell Lynne | Senior VP - CCO | Sell | 2,000 | $9.40 | $18,800.00 | -100% | |
| Jan 18, 2019 | PAHC Phibro Animal Health Corp | Bendheim Daniel M | Exec. VP, Corporate Strategy | Sell | 7,500 | $32.23 | $241,700.00 | -100% | |
| Jan 17, 2019 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 136,577 | $118.33 | $16,161,280.70 | - | |
| Jan 16, 2019 | BCRX Biocryst Pharmaceuticals Inc | Powell Lynne | Senior VP - CCO | Sell | 3,046 | $9.27 | $28,236.42 | -100% | |
| Jan 16, 2019 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 1,657 | $117.87 | $195,314.73 | - | |
| Jan 16, 2019 | AMPH Amphastar Pharmaceuticals, Inc. | Liawatidewi Yakob47 | SVP Corp Admin Center | Sell | 3,183 | $22.15 | $70,503.45 | -4.1% | |
| Jan 15, 2019 | COLL Collegium Pharmaceutical, Inc | Heffernan Michael Thomas | Director | Sell | 25,000 | $15.56 | $389,000.00 | -8.0% | |
| Jan 15, 2019 | PAHC Phibro Animal Health Corp | Warras Dean J | Pres Animal Health &Nutr N.a. | Sell | 21,560 | $31.81 | $685,823.60 | -100% | |
| Jan 15, 2019 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 51,766 | $117.74 | $6,095,135.90 | - | |
| Jan 14, 2019 | BCRX Biocryst Pharmaceuticals Inc | Powell Lynne | Senior VP - CCO | Sell | 954 | $9.20 | $8,776.80 | -100% | |
| Jan 11, 2019 | LFCR Lifecore Biomedical, Inc. \de\ | Powell Andrew Kenneth William | Director | Buy | 525 | $11.62 | $6,100.50 | +110.5% | |
| Jan 11, 2019 | AMRN Amarin Corp Plc\uk | Kennedy Joseph T | General Counsel | Sell | 3,173 | $18.92 | $60,033.16 | -1.4% | |
| Jan 10, 2019 | AMRN Amarin Corp Plc\uk | Stack David M67 | Director | Sell | 125,504 | $18.00 | $2,259,072.00 | -100% | |
| Jan 10, 2019 | AMRN Amarin Corp Plc\uk | Ekman Lars73 | Director | Sell | 140,416 | $17.28 | $2,426,489.35 | -31.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.